Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit and

First Page		Document Content
Date: 2014-07-16 01:09:14 Multiple sclerosis Immune system Autoimmune diseases Natalizumab Treatment of multiple sclerosis Progressive multifocal leukoencephalopathy Fingolimod JC virus Glatiramer acetate Immunology Medicine Immunosuppressants		Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit and Add to Reading List Source URL: protectbenefitrisk.eu Download Document from Source Website File Size: 3,16 MB Share Document on Facebook

	www.edoriumjournals.com CASE REPORT PEER REVIEWED \| OPEN ACCESS DocID: 1qwuZ - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1q98z - View Document
	PDF Document DocID: 1ptj0 - View Document
	JULY 2016 TABLE OF CONTENTS INTRODUCTION DocID: 1pejO - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1oDv5 - View Document